Asuncion Mejias, MD, PhD, MsCS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Sanofi-Pasteur
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Pfizer
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    Investigator Initiated grant to Institution
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
    Relationship end date:
    12/31/2022
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Investigator Initiated grant to Institution
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
Return to 2023 Children's National Pediatric Pulmonology: State-of-the-Art 09/22/2023